Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study

BACKGROUND: The treatment for diabetic macular edema (DME) has revolutionized during the last 15 years after the introduction of intravitreal anti-VEGF agents. The aim of the current study is to evaluate the real-world visual outcomes of diabetic macular edema (DME) treatment in patients with type 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Wirkkala, Joonas, Kubin, Anna-Maria, Ohtonen, Pasi, Yliselä, Joona, Siik, Taru, Hautala, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178825/
https://www.ncbi.nlm.nih.gov/pubmed/35681133
http://dx.doi.org/10.1186/s12886-022-02482-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178825/
https://www.ncbi.nlm.nih.gov/pubmed/35681133
http://dx.doi.org/10.1186/s12886-022-02482-z

Ejemplares similares